基于深度学习的多CT优化:一种考虑头颈部肿瘤调强质子治疗解剖变化的自适应治疗计划方法
本研究提出基于深度学习的多CT调强质子治疗计划框架,利用锥形束CT与计划CT形变配准生成额外CT,并通过U-net模型预测稳健剂量及剂量模拟算法生成可交付计划。回顾性纳入55例头颈部肿瘤患者,结果显示多CT计划较基于计划CT的稳健计划在靶区剂量学上更具稳健性且危及器官受量更低。
要点
- 多CT计划较计划CT稳健计划降低CTV1 D2%(76.1 Gy vs 82.4 Gy)。
- 多CT计划CTV1均匀性指数更优(7.7% vs 16.4%)。
- 多CT计划CTV2适形性指数更优(70.5% vs 61.5%)。
核心结论
- 将每日锥形束CT图像纳入多CT优化具有可行性和优势,可提高计划对解剖变化的稳健性,并可能减少头颈部肿瘤治疗中计划自适应的需求。
研究设计与样本
- 回顾性研究,数据集为55例头颈部肿瘤患者,其中38例为训练集、7例为验证集、10例为测试集用于最终评估。
主要发现
- 通过后续多CT剂量模拟生成的可交付计划比基于计划CT生成的稳健计划表现出更高的稳健性,并改善了危及器官的剂量保护。
- 所有测试患者中,多CT计划的D2%为76.1 Gy,低于计划CT稳健计划的82.4 Gy。
- 所有测试患者中,多CT计划的CTV1均匀性指数为7.7%,优于计划CT稳健计划的16.4%。
- 所有测试患者中,多CT计划的CTV2适形性指数为70.5%,优于计划CT稳健计划的61.5%。
关键数值与推荐
- 多CT计划较计划CT稳健计划:D2% 76.1 Gy vs 82.4 Gy(多CT更低)。
- 多CT计划较计划CT稳健计划:CTV1均匀性指数 7.7% vs 16.4%(多CT更优)。
- 多CT计划较计划CT稳健计划:CTV2适形性指数 70.5% vs 61.5%(多CT更优)。
临床怎么用
- 原文未据此给出临床推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUNDS: Intensity-modulated proton therapy (IMPT) is particularly susceptible to range and setup uncertainties, as well as anatomical changes. PURPOSE: We present a framework for IMPT planning that employs a deep learning method for dose prediction based on multiple-CT (MCT). The extra CTs are created from cone-beam CT (CBCT) using deformable registration with the primary planning CT (PCT). Our method also includes a dose mimicking algorithm. METHODS: The MCT IMPT planning pipeline involves prediction of robust dose from input images using a deep learning model with a U-net architecture. Deliverable plans may then be created by solving a dose mimicking problem with the predictions as reference dose. Model training, dose prediction and plan generation are performed using a dataset of 55 patients with head and neck cancer in this retrospective study. Among them, 38 patients were used as training set, 7 patients were used as validation set, and 10 patients were reserved as test set for final evaluation. RESULTS: We demonstrated that the deliverable plans generated through subsequent MCT dose mimicking exhibited greater robustness than the robust plans produced by the PCT, as well as enhanced dose sparing for organs at risk. MCT plans had lower D2% (76.1 Gy vs. 82.4 Gy), better homogeneity index (7.7% vs. 16.4%) of CTV1 and better conformity index (70.5% vs. 61.5%) of CTV2 than the robust plans produced by the primary planning CT for all test patients. CONCLUSIONS: We demonstrated the feasibility and advantages of incorporating daily CBCT images into MCT optimization. This approach improves plan robustness against anatomical changes and may reduce the need for plan adaptations in head and neck cancer treatments.
引用
- Liu M, Pang B, Chen S, et al. Deep learning-based multiple-CT optimization: An adaptive treatment planning approach to account for anatomical changes in intensity-modulated proton therapy for head and neck cancers. Radiother Oncol. 2024. PMID: 39581351. doi:10.1016/j.radonc.2024.110650
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。